Gilteritinib: Repurposing of AXL‐targeting kinase inhibitors against COVID‐19
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28592
Abstract: The coronavirus disease‐19 (COVID‐19) is an ongoing infection outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a novel positive single‐stranded, enveloped RNA virus belonging to the genus Betacoronavirus. During the pandemic, the SARS‐CoV‐2… read more here.
Keywords: kinase inhibitors; axl targeting; repurposing axl; targeting kinase ... See more keywords
Abstract A140: MERTK mediates intrinsic and adaptive resistance to AXL-targeting agents
Sign Up to like & getrecommendations! Published in 2018 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.targ-17-a140
Abstract: The TAM family of receptor tyrosine kinases (RTKs) has been discovered to play a predominant role in promoting the growth, survival, and metastatic spread of several tumor types. AXL and MERTK are two TAM family… read more here.
Keywords: axl targeting; axl; mertk; resistance axl ... See more keywords